Journal
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY
Volume 5, Issue -, Pages -Publisher
AME PUBLISHING COMPANY
DOI: 10.21037/tgh.2020.01.02
Keywords
Diffuse; gastric; cancer
Categories
Funding
- National Cancer Institute, NIH [P30 CA006927]
Ask authors/readers for more resources
Diffuse gastric cancer (DGC) is a distinct histopathologic and molecular disease, characterized by mutations in CDH1, RHOA, and others. In addition, DGC is associated with familial syndromes, including hereditary DGC and germline mutation in CDH1. Clinically, this subtype of gastric adenocarcinoma is associated with a poor prognosis and possible resistance to available systemic therapies. An understanding of the genetic and molecular underpinnings of DGC may help inform of its clinical behavior and aid in screening, diagnosis, and response to treatment. In this review, we will review the current histologic, molecular, and genetic landscape of DGC and its relevance to clinical practice.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available